Martin Dreyling

Martin Dreyling

Ludwig Maximilians Universität München - Munich / Germany
Others
AD Scientific Index ID: 1761788
Ludwig Maximilian University of Munich
person_outline Martin Dreyling's MOST POPULAR ARTICLES
1-) Revised response criteria for malignant lymphomaBD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ...Journal of clinical oncology 25 (5), 579-586, 200749382007
2-) Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphomaML Wang, S Rule, P Martin, A Goy, R Auer, BS Kahl, W Jurczak, ...New England Journal of Medicine 369 (6), 507-516, 201316352013
3-) Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients …W Hiddemann, M Kneba, M Dreyling, N Schmitz, E Lengfelder, R Schmits, ...Blood 106 (12), 3725-3732, 200516022005
4-) PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphomaAK Gopal, BS Kahl, S De Vos, ND Wagner-Johnston, SJ Schuster, ...New England Journal of Medicine 370 (11), 1008-1018, 201412682014
5-) Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upH Tilly, MG Da Silva, U Vitolo, A Jack, M Meignan, A Lopez-Guillermo, ...Annals of oncology 26, v116-v125, 201511552015